May 29, 2026 FDA Expands Afrezza to Pediatric Diabetes The decision was supported by the phase 3 INHALE-1 trial and additional long-term safety, efficacy, and exposure data. Conexiant
May 29, 2026 FDA Monthly Preview: Key June Decisions to Watch Several FDA decisions across multiple specialties are expected this month. Conexiant
May 27, 2026 Ensitrelvir Reduced COVID After Household Exposure In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10. Conexiant
May 21, 2026 Retatrutide Shows 28% Weight Loss in Phase 3 Trial Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction. Conexiant
May 13, 2026 RFK Jr. Takes Health Agenda on the Road Touring Ohio, RFK Jr. highlights food quality and recovery services while steering attention away from vaccine controversies. Kff Health News
May 13, 2026 RFK Jr. Takes Health Agenda on the Road Touring Ohio, RFK Jr. highlights food quality and recovery services while steering attention away from vaccine controversies. Kff Health News
May 12, 2026 Makary Resigns as FDA Commissioner Following Policy Disputes Transition follows disputes over vaccine policy, food additive regulation, and flavored vaping product authorization Conexiant
May 04, 2026 Food Fight Brewing in Hospitals New federal diet push collides with clinical realities, as doctors weigh patient needs against policy signals. Kff Health News
April 29, 2026 FDA Reports Results of Nationwide Infant Formula Testing Federal testing survey examines chemical contaminant profiles across widely used products Conexiant
April 29, 2026 FDA Monthly Preview: Key May Decisions to Watch Several FDA decisions across multiple specialties are expected this month. Conexiant